Migraines Headaches News & Features

People suffering from regular migraines despite medication might consider investing in a yoga mat.

A number of drugs are used to prevent migraines, but treatment of youngsters has largely been based on the results of adult studies, the international team of researchers pointed out.

The FDA approved a new treatment option for migraine patients who cannot get relief from existing medications once an attack strikes.

The team found that when it came to head pain control, it didn't matter how much tetrahydrocannabinol (THC) or cannabidiol (CBD) was in a particular batch of pot. THC and CBD are the most commonly studied ingredients in marijuana

Migraine sufferers who cannot get relief from existing medications may soon have a novel treatment option, a new trial suggests.

Clinical research now indicates that about half of the people who undergo surgery to release entrapped nerves will experience complete relief from migraines, and another 40% will have fewer and less severe headaches

Stimulating the vagus nerve appears to calm down centers in the brain that cause migraine and vertigo.

The bacteria, from the genus pseudomonas and the genus burkholderia, can enter the bloodstream and cause serious, life-threatening infections.

When researchers weighed other factors -- like income, education and smoking and drinking habits -- people who were concerned about affording groceries were 58% more likely to suffer from migraine headaches.

The FDA has cleared a noninvasive device that uses smartphone-controlled electronic pulses to relieve acute migraine pain.

The study found that -- after adjusting for body weight and other health factors -- women who said they had migraines had a 30 percent lower risk of type 2 diabetes.

The FDA has approved the third of a new type of migraine drug to prevent migraine in adults.

The FDA in May approved a first self-injectable drug, erenumab (Aimovig), made by Amgen and Novartis. It's now offered as once-monthly 70- or 140-milligram prefilled autoinjectors.

Results of new research suggest that changing levels of the female sex hormone estrogen make cells around a key nerve in the head and connected blood vessels more sensitive to migraine triggers, scientists say. And that increases migraine risk.

Little research has looked into the role of hormones in men's migraines, and that research has focused on testosterone, said Dr. Jelena Pavlovic, an assistant professor of neurology at Albert Einstein College of Medicine in New York City.

Previous studies have shown that treatments such as cognitive behavioral therapy, stress management, relaxation techniques and biofeedback may reduce migraine symptoms by 50 percent or more.

Galcanezumab cut in half the number of days that most patients suffered from a migraine in a month, and did so without significant side effects,  researchers reported.

The FDA has approved the first in a new class of migraine drugs, called CGRP inhibitors, that aim to head off fight painful migraine headaches before they start.

The highest rate of migraines is among people of European descent, who also have the highest rate of the cold-adaptive genetic variant, the study authors said.

Researchers found that the injected drug, called erenumab, could prevent migraines if other treatments fail to do so.

Self-administered magnetic pulses from a hand-held device may help head off debilitating migraines, researchers report.

Migraine patients could also face an increased risk of heart attacks, strokes, blood clots and irregular heart rates, a new study suggests.

Norwegian researchers examined the aftermath of a 2011 terrorist attack on a summer camp in Norway that left 69 people dead and 33 severely wounded. Most of the dead were teenagers.

The drugs were designed specifically to target a pathway believed to be important in these headaches.

Non-narcotic drug far more effective in new study